ScholarLens Back to search
2006•Medical Journal of Chinese People's HealthRequires access

The comparative interventional therapies of dyslipidemia by Simvastatin and Zibituo with 100 cases

Fengmei Hu

Open publisher page 1 citations

Abstract

Objective:To evaluate the interventional treatment of dyslipidemia by simvastatin and Zhibituo separately.Methods:The group by simvastatin(50 cases,20mg /day) and the other group by Zhibituo(50 cases,3 tablets/time,3 times /day) took these different treatments for 8 consecutive weeks.Results: Both of the medicines have reduced the cholesterol nitroglycerine and lifted the treatment level of HDL-C in serum about 88% and 90%,88% and 80%,63% and 74%.Conclusions: Both medicines have achieved similar effect in controlling the dyslipidemia.

About this research paper

What this paper is about

Objective:To evaluate the interventional treatment of dyslipidemia by simvastatin and Zhibituo separately.Methods:The group by simvastatin(50 cases,20mg /day) and the other group by Zhibituo(50 cases,3 tablets/time,3 times /day) took these different treatments for 8 consecutive weeks.Results: Both of the medicines have reduced the cholesterol nitroglycerine and lifted the treatment level of HDL-C in serum about 88% and 90%,88% and 80%,63% and 74%.Conclusions: Both medicines have achieved similar effect in controlling the dyslipidemia.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the interventional treatment of dyslipidemia by simvastatin and Zhibituo separately.Methods:The group by simvastatin(50 cases,20mg /day) and the other group by Zhibituo(50 cases,3 tablets/time,3 times /day) took these different treatments for 8 consecutive weeks.Results: Both of the medicines have reduced the cholesterol nitroglycerine and lifted the treatment level of HDL-C in serum about 88% and 90%,88% and 80%,63% and 74%.Conclusions: Both medicines have achieved similar effect in controlling the dyslipidemia.

Key concepts: Simvastatin, Dyslipidemia, Medicine, Internal medicine, Pharmacology, Surgery, Obesity

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The comparative interventional therapies of dyslipidemia by Simvastatin and Zibituo with 100 cases — Research Paper | ScholarLens